Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

KRX:185750 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,038,274	1,178,982	1,665,713	1,001,820	1,312,265	2,572,969
Market Cap Growth	-29.22%	-29.22%	66.27%	-23.66%	-49.00%	145.08%
Enterprise Value	926,665	1,062,300	1,643,506	1,090,150	1,317,515	2,555,288
Last Close Price	78800.00	89000.00	123206.25	72988.82	92946.29	179136.40
PE Ratio	9.57	10.81	7.84	12.38	30.72	28.08
Forward PE	-	14.47	18.84	11.98	14.96	28.32
PS Ratio	0.66	0.74	1.00	0.67	0.98	1.98
PB Ratio	1.16	1.32	2.04	1.61	2.32	4.67
P/TBV Ratio	1.44	1.44	2.18	1.68	2.41	4.83
P/FCF Ratio	40.22	45.67	6.02	43.87	-	35.89
P/OCF Ratio	18.34	18.34	5.24	14.79	101.70	24.66
PEG Ratio	8.17	8.17	8.17	8.17	8.17	8.17
EV/Sales Ratio	0.58	0.67	0.98	0.73	0.98	1.96
EV/EBITDA Ratio	6.66	7.63	5.80	7.60	10.78	17.30
EV/EBIT Ratio	9.32	10.68	6.67	9.92	13.90	20.62
EV/FCF Ratio	35.90	41.15	5.93	47.74	-	35.65
Debt / Equity Ratio	0.21	0.21	0.27	0.38	0.42	0.25
Debt / EBITDA Ratio	1.35	1.35	0.77	1.64	1.94	0.92
Debt / FCF Ratio	7.29	7.29	0.79	10.32	-	1.90
Asset Turnover	1.11	1.11	1.32	1.37	1.35	1.49
Inventory Turnover	3.43	3.43	3.79	3.82	4.13	4.87
Quick Ratio	1.63	1.63	1.32	1.16	1.30	1.19
Current Ratio	2.61	2.61	1.85	1.91	2.08	1.87
Return on Equity (ROE)	13.02%	13.02%	29.73%	13.47%	7.58%	17.61%
Return on Assets (ROA)	4.35%	4.35%	12.20%	6.33%	5.94%	8.86%
Return on Capital (ROIC)	5.87%	5.87%	16.29%	8.28%	7.95%	12.10%
Return on Capital Employed (ROCE)	9.10%	9.10%	27.70%	14.60%	13.00%	19.80%
Earnings Yield	10.51%	9.25%	12.76%	8.08%	3.26%	3.56%
FCF Yield	2.49%	2.19%	16.63%	2.28%	-2.69%	2.79%
Payout Ratio	12.22%	12.22%	5.46%	13.88%	25.30%	10.12%
Buyback Yield / Dilution	5.20%	5.20%	-3.79%	1.77%	0.73%	0.06%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.